Related Experiment Video

Updated: Feb 10, 2026

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.8K

The heparan sulfate proteoglycan grip on hyperlipidemia and atherosclerosis

Philip L S M Gordts1, Jeffrey D Esko2

  • 1Department of Medicine, Division of Endocrinology and Metabolism, University of California, San Diego, La Jolla, CA, USA; Glycobiology Research and Training Center, University of California, San Diego, La Jolla, CA, USA.

Matrix Biology : Journal of the International Society for Matrix Biology
|May 28, 2018
PubMed

Insights

Heparan sulfate proteoglycans influence lipid homeostasis and inflammation, key factors in atherosclerosis. Understanding these interactions offers new strategies for managing cardiovascular disease risk.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Cardiovascular Research

Background:

  • Heparan sulfate proteoglycans (HSPGs) are crucial cell surface and extracellular matrix components.
  • HSPGs interact with numerous proteins regulating lipid homeostasis and inflammation.
  • Cardiovascular diseases, primarily atherosclerosis, are a leading cause of mortality worldwide.

Purpose of the Study:

  • To explore the role of HSPGs in modulating cardiovascular disease risk factors.
  • To elucidate the mechanisms by which HSPGs influence hyperlipidemia and inflammation in atherosclerosis.

Main Methods:

  • Literature review of recent findings on HSPG function in cardiovascular disease.
  • Analysis of molecular interactions between HSPGs and proteins involved in lipid metabolism and inflammatory pathways.

Main Results:

  • HSPGs significantly impact lipid levels and inflammatory responses.
  • These modulations by HSPGs are critical in the initiation and progression of atherosclerotic plaques.

Conclusions:

  • HSPGs represent a significant therapeutic target for cardiovascular disease.
  • Further research into HSPG-protein interactions can lead to novel treatments for atherosclerosis and related complications.

More Related Videos

Measurement of Spatial Stability in Precision Grip09:36

Measurement of Spatial Stability in Precision Grip

Published on: June 4, 2020

3.6K
Quantification of Atherosclerosis in Mice06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

40.4K

Related Concept Videos

Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
4.9K
Matrix Proteoglycans and Glycoproteins01:21

Matrix Proteoglycans and Glycoproteins

Proteoglycans are extensively glycosylated proteins, commonly found in the extracellular matrix, interwoven with collagen fibers. Hyaline cartilage, the most common type of cartilage in the body, consists of short and dispersed collagen fibers associated with large amounts of proteoglycans. These proteoglycans have long negative charges that attract cations, which in turn attract water molecules. This influx of ions and water molecules swells up the proteoglycan like a water-soaked gel that can...
5.1K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
440
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.1K
Sulfate Attack on Concrete01:29

Sulfate Attack on Concrete

Sulfate attack on concrete is a deterioration process characterized by a whitish discoloration beginning at the edges and corners, accompanied by cracking and spalling. This phenomenon occurs when sulfates react with the components of hardened concrete, forming compounds like calcium sulfate and calcium sulfoaluminate which occupy more space than the substances they replace, causing the concrete to expand and disrupt.
Sulfates from sources like soil, groundwater, or industrial effluents...
771
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
554